Astex Pharmaceuticals To Present At Investor Conferences In September

DUBLIN, Calif., Sept. 3, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that management team members will present and meet with investors at three banking conferences this month:

Rodman & Renshaw Annual Global Investment Conference Monday, September 9th at 12:30 pm ET New York

Morgan Stanley Global Healthcare Conference Wednesday, September 11th at 10:00 am ET New York

Stifel Healthcare Conference 2013 Wednesday, September 11th at 10:20 am ET Boston

Live webcasts of the presentations will be available in the Investor Events section of the Company's website, www.astx.com. The webcasts will be archived for 30 days.

About Astex Pharmaceuticals

Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals developed DACOGENĀ® (decitabine) for Injection and receives significant royalties on global sales.

For more information about Astex Pharmaceuticals, Inc., please visit http://www.astx.com.
CONTACTS: Timothy L. Enns          Astex Pharmaceuticals, Inc.          Senior Vice President          Corporate Communications & Marketing          Tel: +1 (925) 560-2810          E-mail: tim.enns@astx.com                   Susanna Chau          Astex Pharmaceuticals, Inc.          Manager          Investor Relations          Tel: +1 (925) 560-2845          E-mail: susanna.chau@astx.com                   Alan Roemer          The Trout Group          Managing Director          Tel: +1 (646) 378-2945          E-mail: aroemer@troutgroup.com

Astex Pharmaceuticals, Inc. logo